Class II
Ongoing
Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for…
Why: Failed Dissolution Specifications.
- Company
- MACLEODS PHARMA USA, INC
Princeton, NJ, United States - Reported
- Nov 4, 2026
- Recall started
- Oct 7, 2026
- Where sold
- Nationwide in the USA
- Amount
- 3528 30-count and 216 90-count bottles
- Full product description
- Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India
- Lots / codes affected
- Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.